Puma Biotechnology
PBYI
PBYI
133 hedge funds and large institutions have $274M invested in Puma Biotechnology in 2019 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 57 increasing their positions, 36 reducing their positions, and 27 closing their positions.
Holders
133
Holders Change
-11
Holders Change %
-7.64%
% of All Funds
2.63%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
18
Increased
57
Reduced
36
Closed
27
Calls
$6.83M
Puts
$6.21M
Net Calls
+$624K
Net Calls Change
+$2.01M
Top Buyers
| 1 |
1
Millennium Management
New York
|
$16.2M |
| 2 |
2
State Street
Boston,
Massachusetts
|
$30.7M |
| 3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$34.9M |
| 4 |
4
Acadian Asset Management
Boston,
Massachusetts
|
$7.34M |
| 5 |
DM
5
Deerfield Management
New York
|
$3.47M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MWNA
151
Marshall Wace North America
New York
| – | -$108K | -10,057 | Closed |
|
152
Victory Capital Management
San Antonio,
Texas
| – | -$62K | -5,770 | Closed |
|
153
Rockefeller Capital Management
New York
| – | -$53K | -4,900 | Closed |
|
|
FMT
154
First Mercantile Trust
Cordova,
Tennessee
| – | -$20K | -1,890 | Closed |
|
|
RA
155
Royce & Associates
New York
| – | -$19K | -1,749 | Closed |
|